Page 7 - Cures Act News Today

The patient-centric data economy is a new frontier where disease-ending insights for everyone are at the forefront. Array Insights CEO shares

The healthcare industry can deploy test automation practices to ensure the quality of the healthcare software used to provide patent care.

As of September 1, 2023, the U.S. Department of Health and Human Services (“HHS”) Office of Inspector General (“OIG”) can officially begin enforcement against Certified Health...

CMC

The U.S. Food and Drug Administration is approving more novel pharmaceutical drugs based on single clinical trials and with less public disclosure about those trials than was the norm just

Clinicians and consumers are deprived of the full picture needed for informed decision-making

The U.S. Food and Drug Administration is approving more novel pharmaceutical drugs based on single clinical trials and with less public disclosure about those trials than was the norm just

Zak, CEO of Hint Health, is on a mission to transform the healthcare landscape by fostering a direct link between patients and doctors through the Direct Primary Care (DPC) movement. He discusses his role, experience, and the intersection of healthcare, technology, and venture capital.

The U.S. Food and Drug Administration is approving more novel pharmaceutical drugs based on single clinical trials and with less public disclosure about those trials than was the norm just a few years ago, a pair of recent studies from Oregon State University found.

Legislative proposals to protect reproductive health data in Maryland could set a precedent in the United States, says Nichole Sweeney,general counsel and chief privacy officer at CRISP, the state-designated health information exchange of Maryland, and CRISP Shared Services, a nonprofit infrastructure organization supporting six HIEs across the U.S. In a Q&A with Healthcare IT News, Sweeney also explains why electronic health record vendors can better partner with healthcare organizations t...